PharmaVoice 29. Jan. 2026 Eli Lilly, BioAge chase NLRP3 inhibitors with ‘pipeline in a pill’ potential
PharmaVoice 24. Nov. 2025 Eli Lilly becomes first drugmaker to hit $1 trillion in market value #Eli Lilly #drugmaking peers